Johnny Daniels

558 total citations
24 papers, 376 citations indexed

About

Johnny Daniels is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Johnny Daniels has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 19 papers in Epidemiology and 3 papers in Economics and Econometrics. Recurrent topics in Johnny Daniels's work include Tuberculosis Research and Epidemiology (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Pneumonia and Respiratory Infections (8 papers). Johnny Daniels is often cited by papers focused on Tuberculosis Research and Epidemiology (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Pneumonia and Respiratory Infections (8 papers). Johnny Daniels collaborates with scholars based in South Africa, United States and Belgium. Johnny Daniels's co-authors include Helen Cox, Jennifer Hughes, Gilles Van Cutsem, Vivian Cox, Sizulu Moyo, Erika Mohr-Holland, Virginia De Azevedo, Odelia Muller, Jennifer Furin and Mark P. Nicol and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Johnny Daniels

22 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnny Daniels South Africa 12 307 273 65 34 30 24 376
Ashaque Husain Bangladesh 10 265 0.9× 207 0.8× 67 1.0× 21 0.6× 34 1.1× 12 310
Chandra Suresh India 7 187 0.6× 112 0.4× 35 0.5× 19 0.6× 24 0.8× 13 252
Ron Rosenes Canada 11 187 0.6× 172 0.6× 53 0.8× 39 1.1× 11 0.4× 31 392
Valiantsin Rusovich Denmark 6 274 0.9× 227 0.8× 93 1.4× 33 1.0× 11 0.4× 13 337
Erik Post Netherlands 10 313 1.0× 142 0.5× 144 2.2× 24 0.7× 11 0.4× 25 378
Janet Nicotera United States 8 389 1.3× 182 0.7× 14 0.2× 24 0.7× 51 1.7× 12 515
Mike Frick United States 10 168 0.5× 149 0.5× 30 0.5× 42 1.2× 13 0.4× 30 294
Kamal Kishore Chopra India 8 146 0.5× 94 0.3× 43 0.7× 20 0.6× 8 0.3× 24 214
Demeke Geremew Ethiopia 10 179 0.6× 159 0.6× 49 0.8× 40 1.2× 15 0.5× 28 293
Erik George United States 6 285 0.9× 110 0.4× 14 0.2× 35 1.0× 46 1.5× 13 380

Countries citing papers authored by Johnny Daniels

Since Specialization
Citations

This map shows the geographic impact of Johnny Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Daniels more than expected).

Fields of papers citing papers by Johnny Daniels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Daniels. The network helps show where Johnny Daniels may publish in the future.

Co-authorship network of co-authors of Johnny Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of Johnny Daniels. A scholar is included among the top collaborators of Johnny Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnny Daniels. Johnny Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goig, Galo A., Fabrizio Menardo, Anzaan Dippenaar, et al.. (2023). Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study. The Lancet Microbe. 4(7). e506–e515. 20 indexed citations
2.
Cox, Helen, Johnny Daniels, Shaheed Mathee, et al.. (2023). Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household. Open Forum Infectious Diseases. 10(3). ofad087–ofad087. 3 indexed citations
3.
Mohr-Holland, Erika, Johnny Daniels, Vera Scott, et al.. (2022). Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa. Public Health Action. 12(2). 55–57. 3 indexed citations
4.
Mohr-Holland, Erika, Johnny Daniels, Anja Reuter, et al.. (2022). Early mortality during rifampicin-resistant TB treatment. The International Journal of Tuberculosis and Lung Disease. 26(2). 150–157. 6 indexed citations
5.
Reuter, Anja, Jennifer Furin, Johnny Daniels, et al.. (2022). Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa. Tropical Medicine and Infectious Disease. 7(2). 21–21. 3 indexed citations
6.
Cox, Helen, Galo A. Goig, Anzaan Dippenaar, et al.. (2022). Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study. Journal of Clinical Microbiology. 60(3). e0236221–e0236221. 19 indexed citations
7.
8.
Mohr-Holland, Erika, Johnny Daniels, Jennifer Furin, et al.. (2021). Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients. The Pediatric Infectious Disease Journal. 40(5). e191–e192. 10 indexed citations
9.
Loveday, Marian, et al.. (2021). “This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. PLoS ONE. 16(10). e0251482–e0251482. 7 indexed citations
10.
Vos, Margaretha de, Serej D. Ley, Brigitta Derendinger, et al.. (2021). Emergence of resistance to bedaquiline. International Journal of Mycobacteriology. 10(Suppl 1). S12–S12.
11.
Streicher, Elizabeth M., Frederick A. Sirgel, Fabrizio Menardo, et al.. (2021). Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa. Antimicrobial Agents and Chemotherapy. 65(11). e0036421–e0036421. 9 indexed citations
12.
Mohr-Holland, Erika, Jennifer Hughes, Anja Reuter, et al.. (2018). Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. European Respiratory Journal. 51(6). 1800017–1800017. 27 indexed citations
13.
Mohr-Holland, Erika, Johnny Daniels, Petros Isaakidis, et al.. (2017). DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLoS ONE. 12(5). e0178054–e0178054. 11 indexed citations
14.
Mohr-Holland, Erika, Johnny Daniels, Odelia Muller, et al.. (2017). Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. The International Journal of Tuberculosis and Lung Disease. 21(10). 1100–1105. 6 indexed citations
15.
Mohr-Holland, Erika, Vivian Cox, Lynne Wilkinson, et al.. (2015). Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 109(7). 425–432. 18 indexed citations
16.
Daniels, Johnny, Mohammed Khogali, Erika Mohr-Holland, et al.. (2015). Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success. PLoS ONE. 10(11). e0142873–e0142873. 12 indexed citations
17.
Moyo, Sizulu, Helen Cox, Jennifer Hughes, et al.. (2015). Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa. PLoS ONE. 10(3). e0118919–e0118919. 30 indexed citations
18.
Cox, Helen, Johnny Daniels, Odelia Muller, et al.. (2015). Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa. Open Forum Infectious Diseases. 2(1). ofv014–ofv014. 59 indexed citations
19.
Cox, Helen, Jennifer Hughes, Johnny Daniels, et al.. (2014). Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. The International Journal of Tuberculosis and Lung Disease. 18(4). 441–448. 75 indexed citations
20.
Babor, Thomas F., et al.. (1997). Alcohol screening and brief intervention: where research meets practice.. PubMed. 61(9). 565–75. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashaque Husain Breakdown of academic impact, for papers by Chandra Suresh Breakdown of academic impact, for papers by Ron Rosenes Breakdown of academic impact, for papers by Valiantsin Rusovich Breakdown of academic impact, for papers by Erik Post Breakdown of academic impact, for papers by Janet Nicotera Breakdown of academic impact, for papers by Mike Frick Breakdown of academic impact, for papers by Kamal Kishore Chopra Breakdown of academic impact, for papers by Demeke Geremew Breakdown of academic impact, for papers by Erik George
Rankless by CCL
2026